<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36982589</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>The Long Term Residual Effects of COVID-Associated Coagulopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5514</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24065514</ELocationID><Abstract><AbstractText>During the acute phase of COVID-19, many patients experience a complex coagulopathy characterized by a procoagulant pattern. The present study investigates the persistence of hemostatic changes in post-COVID patients at a long-term follow up, and the link with the persistence of physical and neuropsychological symptoms. We completed a prospective cohort study on 102 post-COVID patients. Standard coagulation and viscoelastic tests were performed, along with an assessment of persistent symptoms and recording of acute phase details. A procoagulant state was adjudicated in the presence of fibrinogen &gt; 400 mg/dL, or D-dimer &gt; 500 ng/mL, or platelet count &gt; 450,000 cells/&#xb5;L, or a maxim clot lysis at viscoelastic test &lt; 2%. A procoagulant state was identified in 75% of the patients at 3 months follow up, 50% at 6 months, and 30% at 12-18 months. Factors associated with the persistence of a procoagulant state were age, severity of the acute phase, and persistence of symptoms. Patients with major physical symptoms carry a procoagulant state relative risk of 2.8 (95% confidence interval 1.17-6.7, <i>p</i> = 0.019). The association between persistent symptoms and a procoagulant state raises the hypothesis that an ongoing process of thrombi formation and/or persistent microthrombosis may be responsible for the main physical symptoms in long-COVID patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ranucci</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-4915-3572</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baryshnikova</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anguissola</LastName><ForeName>Martina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7132-2782</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8168-8254</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Anesthesia and Intensive Care, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falco</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, Koelliker Hospital, 10134 Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menicanti</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Scientific Directorate, IRCCS Policlinico San Donato, 20097 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>N/A</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="Y">Blood Coagulation Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">coagulopathy</Keyword><Keyword MajorTopicYN="N">fibrinolysis</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>M.R. received research grants and a speaker&#x2019;s fee from CSL Behring and a speaker&#x2019;s fee from Werfen and LFB. E.B. has received speakers&#x2019; fees from Stago and a travel grant from HemoSonics. Other authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36982589</ArticleId><ArticleId IdType="pmc">PMC10049638</ArticleId><ArticleId IdType="doi">10.3390/ijms24065514</ArticleId><ArticleId IdType="pii">ijms24065514</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ranucci M., Ballotta A., Di Dedda U., Baryshnikova E., Poli M.D., Resta M., Falco M., Albano G., Menicanti L. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J. Thromb. Haemost. 2020;18:1747&#x2013;1751. doi: 10.1111/jth.14854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14854</ArticleId><ArticleId IdType="pmc">PMC9906332</ArticleId><ArticleId IdType="pubmed">32302448</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranucci M., Sitzia C., Baryshnikova E., Di Dedda U., Cardani R., Martelli F., Corsi Romanelli M. COVID-19-Associated Coagulopathy: Biomarkers of Thrombin Generation and Fibrinolysis Leading the Outcome. J. Clin. Med. 2020;9:3487. doi: 10.3390/jcm9113487.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9113487</ArticleId><ArticleId IdType="pmc">PMC7692774</ArticleId><ArticleId IdType="pubmed">33126772</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada M., Bottino N., Tagliabue P., Grasselli G., Novembrino C., Chantarangkul V., Pesenti A., Peyvandi F., Tripodi A. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 2020;18:1738&#x2013;1742. doi: 10.1111/jth.14850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasi A., von Meijenfeldt F.A., Adelmeijer J., Calvo A., Iba&#xf1;ez C., Perdomo J., Reverter J.C., Lisman T. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation. J. Thromb. Haemost. 2020;18:2646&#x2013;2653. doi: 10.1111/jth.15043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15043</ArticleId><ArticleId IdType="pmc">PMC7436627</ArticleId><ArticleId IdType="pubmed">32762118</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H., Song F., Van Cott E.M., Kuter D.J., Rosovsky R. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19) Am. J. Hematol. 2020;95:1479&#x2013;1485. doi: 10.1002/ajh.25962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25962</ArticleId><ArticleId IdType="pmc">PMC7436379</ArticleId><ArticleId IdType="pubmed">32780525</ArticleId></ArticleIdList></Reference><Reference><Citation>Nougier C., Benoit R., Simon M., Desmurs-Clavel H., Marcotte G., Argaud L., David J.S., Bonnet A., Negrier C., Dargaud Y. Hypofibrinolytic state and high thrombin generation may play a major role in SARS-CoV-2 associated thrombosis. J. Thromb. Haemost. 2020;18:2215&#x2013;2219. doi: 10.1111/jth.15016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15016</ArticleId><ArticleId IdType="pmc">PMC7405476</ArticleId><ArticleId IdType="pubmed">32668058</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett T.J., Lee A.H., Xia Y., Lin L.H., Black M., Cotzia P., Hochman J., Berger J.S. Platelet and Vascular Biomarkers Associate With Thrombosis and Death in Coronavirus Disease. Circ. Res. 2020;127:945&#x2013;947. doi: 10.1161/CIRCRESAHA.120.317803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317803</ArticleId><ArticleId IdType="pmc">PMC7478197</ArticleId><ArticleId IdType="pubmed">32757722</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid Y., Puhm F., Allaeys I., Naya A., Oudghiri M., Khalki L., Limami Y., Zaid N., Sadki K., Ben El Haj R., et al. Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19. Circ. Res. 2020;127:1404&#x2013;1418. doi: 10.1161/CIRCRESAHA.120.317703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Prabhakaran P., Ware L.B., White K.E., Cross M.T., Matthay M.A., Olman M.A. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2003;285:L20&#x2013;L28. doi: 10.1152/ajplung.00312.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00312.2002</ArticleId><ArticleId IdType="pubmed">12730079</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi J.J., Wehmeyer G.T., Li H.A., Alshak M.N., Nahid M., Rajan M., Liu B., Schatoff E.M., Elahjji R., Abdelghany Y., et al. D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19. Thromb. Res. 2020;196:318&#x2013;321. doi: 10.1016/j.thromres.2020.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.09.022</ArticleId><ArticleId IdType="pmc">PMC7495176</ArticleId><ArticleId IdType="pubmed">32977130</ArticleId></ArticleIdList></Reference><Reference><Citation>Naymagon L., Zubizarreta N., Feld J., van Gerwen M., Alsen M., Thibaud S., Kessler A., Venugopal S., Makki I., Qin Q., et al. Admission D-dimer levels, D-dimer trends, and outcomes in COVID-19. Thromb. Res. 2020;196:99&#x2013;105. doi: 10.1016/j.thromres.2020.08.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.08.032</ArticleId><ArticleId IdType="pmc">PMC7439969</ArticleId><ArticleId IdType="pubmed">32853982</ArticleId></ArticleIdList></Reference><Reference><Citation>Chocron R., Duceau B., Gendron N., Ezzouhairi N., Khider L., Trimaille A., Goudot G., Weizman O., Alsac J.M., Pommier T., et al. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study. Arch. Cardiovasc. Dis. 2021;114:381&#x2013;393. doi: 10.1016/j.acvd.2021.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.acvd.2021.02.003</ArticleId><ArticleId IdType="pmc">PMC7942155</ArticleId><ArticleId IdType="pubmed">33846096</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervaise A., Bouzad C., Peroux E., Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur. Radiol. 2020;30:6170&#x2013;6177. doi: 10.1007/s00330-020-06977-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-020-06977-5</ArticleId><ArticleId IdType="pmc">PMC7280685</ArticleId><ArticleId IdType="pubmed">32518989</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang C., Garzillo G., Batohi B., Teo J.T.H., Berovic M., Sidhu P.S., Robbie H. Extent of pulmonary thromboembolic disease in patients with COVID-19 on CT: Relationship with pulmonary parenchymal disease. Clin. Radiol. 2020;75:780&#x2013;788. doi: 10.1016/j.crad.2020.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crad.2020.07.002</ArticleId><ArticleId IdType="pmc">PMC7351373</ArticleId><ArticleId IdType="pubmed">32684301</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S., Chen S., Li X., Siu S., Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 2020;18:1421&#x2013;1424. doi: 10.1111/jth.14830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., Van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., et al. Incidence of thrombotic complications in critically ill ICU patiens with COVID-19. Thromb. Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhinaya S., Baskaran V., Dillibabu E., Hemanth S., Abdul Rahman H., Srinvasan K. Systemic arterio-venous thrombosis in COVID-19: A pictorial review. World J. Radiol. 2021;13:19&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852348</ArticleId><ArticleId IdType="pubmed">33574991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaivani M.K., Dinakar S. Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center. Biomark Med. 2022;16:833&#x2013;838. doi: 10.2217/bmm-2022-0050.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2022-0050</ArticleId><ArticleId IdType="pubmed">35787147</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., Farrelly C.O., Conlon N., Bourke N.M., et al. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J. Thromb. Haemost. 2021;19:1064&#x2013;1070. doi: 10.1111/jth.15267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15267</ArticleId><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Wong S.W., Sum C.L.L., Lim G.H., Leung B.P., Tan C.W., Ramanathan K., Dalan R., Cheung C., Lim X.R., et al. Hypercoagulability, endotheliopathy, and inflammation approximating 1&#x2009;year after recovery: Assessing the long-term outcomes in COVID-19 patients. Am. J. Hematol. 2022;97:915&#x2013;923. doi: 10.1002/ajh.26575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.26575</ArticleId><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerotziafas G.T., Van Dreden P., Sergentanis T.N., Politou M., Rousseau A., Grusse M., Sabbah M., Elalamy I., Pappa V., Skourti T., et al. Persisting endothelial cell activation and hypercoagulability after COVID-19 recovery&#x2014;The Prospective Observational ROADMAP-PostCOVID-19 study. Hemato. 2022;3:111&#x2013;121. doi: 10.3390/hemato3010010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/hemato3010010</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Meijenfeldt F.A., Th&#xe5;lin C., Lisman T. Sustained prothrombotic changes in convalescent patients with COVID-19. Lancet Haematol. 2021;8:e475. doi: 10.1016/S2352-3026(21)00146-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(21)00146-0</ArticleId><ArticleId IdType="pmc">PMC8219290</ArticleId><ArticleId IdType="pubmed">34171275</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen N.D., Rollins-Raval M.A., Raval J.S., Thachil J. Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19? Thromb. Res. 2022;210:1&#x2013;3. doi: 10.1016/j.thromres.2021.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.12.012</ArticleId><ArticleId IdType="pmc">PMC8686202</ArticleId><ArticleId IdType="pubmed">34953317</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamayo-Velasco A., Bomb&#xed;n-Canal C., Cebeira M.J., Prada L.S.-D., Miramontes-Gonz&#xe1;lez J.P., Mart&#xed;n-Fern&#xe1;ndez M., Pe&#xf1;arrubia-Ponce M.J. Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic. J. Clin. Med. 2022;11:3443. doi: 10.3390/jcm11123443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11123443</ArticleId><ArticleId IdType="pmc">PMC9225147</ArticleId><ArticleId IdType="pubmed">35743512</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vita A., De Matteis G., d&#x2019;Aiello A., Ravenna S.E., Liuzzo G., Lanza G.A., Massetti M., Crea F., Gasbarrini A., Franceschi F., et al. Incidence and Predictors of Thrombotic Complications in 4272 Patients with COVID-19 or Other Acute Infectious Respiratory Diseases: A Propensity Score-Matched Study. J. Clin. Med. 2021;10:4973. doi: 10.3390/jcm10214973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10214973</ArticleId><ArticleId IdType="pmc">PMC8584832</ArticleId><ArticleId IdType="pubmed">34768490</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I., Fonseca-Rodr&#xed;guez O., Farrington P., Jerndal H., Lundevaller E.H., Sund M., Lindmark K., Connolly A.-M.F. Risks of deep vein thrombosis, pulmonary embolism, and bleeding after COVID-19: Nationwide self-controlled cases series and matched cohort study. BMJ. 2022;377:e069590. doi: 10.1136/bmj-2021-069590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., Conti C., Biffi A.M., Spada M.S., Bondi E., et al. Post COVID-19 sequelae of the respiratory system. A single center experience reporting the compromise of the airway, alveolar and vascular components. Monaldi Arch. Chest. Dis. 2022 doi: 10.4081/monaldi.2022.2412.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2022.2412</ArticleId><ArticleId IdType="pubmed">36226558</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturelli S., Benatti S.V., Casati M., Binda F., Zuglian G., Imeri G., Conti C., Biffi A.M., Spada M.S., Bondi E., et al. Surviving COVID-19 in Bergamo province: A post-acute outpatient re-evaluation. Epidemiol. Infect. 2021;149:e32. doi: 10.1017/S0950268821000145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268821000145</ArticleId><ArticleId IdType="pmc">PMC7873454</ArticleId><ArticleId IdType="pubmed">33461632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouzarou A., Ioannou M., Leonidou E., Chaziri I. Pulmonary Embolism in Post-COVID-19 Patients, a Literature Review: Red Flag for Increased Awareness? SN Compr. Clin. Med. 2022;4:190. doi: 10.1007/s42399-022-01273-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-022-01273-3</ArticleId><ArticleId IdType="pmc">PMC9389494</ArticleId><ArticleId IdType="pubmed">35999860</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan R.T., Gopalan D., Howard L., Vicente A., Park M., Manalan K., Wallner I., Marsden P., Dave S., Branley H., et al. Beyond the clot: Perfusion imaging of the pulmonary vasculature after COVID-19. Lancet Respir. Med. 2021;9:107&#x2013;116. doi: 10.1016/S2213-2600(20)30407-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30407-0</ArticleId><ArticleId IdType="pmc">PMC7833494</ArticleId><ArticleId IdType="pubmed">33217366</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>